Patient shielding provides negligible benefits while increasing risks

April 08, 2019

Leesburg, VA, April 8, 2019--A new study published in the April 2019 issue of the American Journal of Roentgenology (AJR) makes the case for why it is time to abandon the practice of patient shielding in radiology.

The article, "Patient Shielding in Diagnostic Imaging: Discontinuing a Legacy Practice" reviews the historical rationale for patient shielding, and why the risks that come with patient shielding now outweigh what little benefit still exists, if any.

Patient shielding was first introduced as a regulation in 1976 and the wording has not changed since the initial version was released. The regulation was intended to protect from the hereditary risks of radiation exposure. However, as the authors note, no hereditary effects have been observed in humans in the four decades since the regulation was introduced.

The authors also point out that radiation doses have decreased significantly in recent decades thanks to advances in imaging technology. For instance, radiation doses to patients undergoing anteroposterior examinations of the pelvis have decreased more than 96% over the last 60 years. They also point out that as more imaging technologies rely on automatic exposure control, patient shields can lead to an increase in radiation doses and a decrease in image quality if they obstruct the field of view.

"Although the need to abandon this practice is clear, it is incumbent on health care professionals to help patients feel confident about the care they receive," the authors said. "This is especially important regarding issues of radiation risk, for which misinformation is rampant. Consequently, how to address patient concerns as facilities stop providing patient shielding should be considered."
Rebecca Milman Marsh, MD, one of the authors of the study, will discuss the article during an AJR Live Webinar on April 17, at 12 PM Eastern Time.

Founded in 1900, ARRS is the first and oldest radiology society in the United States, and is an international forum for progress in radiology. The Society's mission is to improve health through a community committed to advancing knowledge and skills in radiology. ARRS achieves its mission through an annual scientific and educational meeting, publication of the American Journal of Roentgenology (AJR) and InPractice magazine, topical symposia and webinars, and print and online educational materials. ARRS is located in Leesburg, VA.

American Roentgen Ray Society

Related Radiation Articles from Brightsurf:

Sheer protection from electromagnetic radiation
A printable ink that is both conductive and transparent can also block radio waves.

What membrane can do in dealing with radiation
USTC recently found that polymethylmethacrylate (PMMA) and polyvinyl chloride (PVC) can release acidic substance under γ radiation, whose amount is proportional to the radiation intensity.

First measurements of radiation levels on the moon
In the current issue (25 September) of the prestigious journal Science Advances, Chinese and German scientists report for the first time on time-resolved measurements of the radiation on the moon.

New biomaterial could shield against harmful radiation
Northwestern University researchers have synthesized a new form of melanin enriched with selenium.

A new way to monitor cancer radiation therapy doses
More than half of all cancer patients undergo radiation therapy and the dose is critical.

Nimotuzumab-cisplatin-radiation versus cisplatin-radiation in HPV negative oropharyngeal cancer
Oncotarget Volume 11, Issue 4: In this study, locally advanced head and neck cancer patients undergoing definitive chemoradiation were randomly allocated to weekly cisplatin - radiation {CRT arm} or nimotuzumab -weekly cisplatin -radiation {NCRT arm}.

Breaking up amino acids with radiation
A new experimental and theoretical study published in EPJ D has shown how the ions formed when electrons collide with one amino acid, glutamine, differ according to the energy of the colliding electrons.

Radiation breaks connections in the brain
One of the potentially life-altering side effects that patients experience after cranial radiotherapy for brain cancer is cognitive impairment.

Fragmenting ions and radiation sensitizers
The anti-cancer drug 5-fluorouracil (5FU) acts as a radiosensitizer: it is rapidly taken up into the DNA of cancer cells, making the cells more sensitive to radiotherapy.

'Seeing the light' behind radiation therapy
Delivering just the right dose of radiation for cancer patients is a delicate balance in their treatment regime.

Read More: Radiation News and Radiation Current Events is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to